Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
Offer Description AS PART OF THE PROJECT “ PNRR” Translational research targeting fibrosis regression, endothelial dysfunction reversal, and hepatocyte regeneration in advanced liver diseases—3RE-VALID
-
Offer Description AS PART OF THE PROJECT “ PNRR” Translational research targeting fibrosis regression, endothelial dysfunction reversal, and hepatocyte regeneration in advanced liver diseases—3RE-VALID
-
Offer Description AS PART OF THE PROJECT “ PNRR” Translational research targeting fibrosis regression, endothelial dysfunction reversal, and hepatocyte regeneration in advanced liver diseases—3RE-VALID
-
Offer Description AS PART OF THE PROJECT “ PNRR” Translational research targeting fibrosis regression, endothelial dysfunction reversal, and hepatocyte regeneration in advanced liver diseases—3RE-VALID
-
Offer Description AS PART OF THE PROJECT “ PNRR” Translational research targeting fibrosis regression, endothelial dysfunction reversal, and hepatocyte regeneration in advanced liver diseases—3RE-VALID
-
Offer Description AS PART OF THE PROJECT “ PNRR” Translational research targeting fibrosis regression, endothelial dysfunction reversal, and hepatocyte regeneration in advanced liver diseases—3RE-VALID
-
Offer Description AS PART OF THE PROJECT “ PNRR” Translational research targeting fibrosis regression, endothelial dysfunction reversal, and hepatocyte regeneration in advanced liver diseases—3RE-VALID
-
Offer Description AS PART OF THE PROJECT “ PNRR” Translational research targeting fibrosis regression, endothelial dysfunction reversal, and hepatocyte regeneration in advanced liver diseases—3RE-VALID
-
Offer Description AS PART OF THE PROJECT “ PNRR” Translational research targeting fibrosis regression, endothelial dysfunction reversal, and hepatocyte regeneration in advanced liver diseases—3RE-VALID
-
Offer Description AS PART OF THE PROJECT “ PNRR” Translational research targeting fibrosis regression, endothelial dysfunction reversal, and hepatocyte regeneration in advanced liver diseases—3RE-VALID